A 33-year-old woman with morbid obesity

JAMA

Volumn 283, Issue 24, 2000, Pages 3236-3243

  Atkinson, Richard L ^a   Hartman, Erin E ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; MEDROXYPROGESTERONE ACETATE; PHENTERMINE; POTASSIUM CHLORIDE;

ADULT; BODY MASS; CASE REPORT; COMORBIDITY; DIET; EXERCISE; FEMALE; HUMAN; MORBID OBESITY; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0034725394     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.24.3236     Document Type: Review

References (55)

1. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP, Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res. 1997;5:542-548.
2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes. 1998;22:39-47.
3. Preventing and managing the global epidemic of obesity: report of a WHO Consultation on Obesity. Geneva, Switzerland, June 3-5, 1997. Geneva, Switzerland: WHO; 1998. WHO/NUT/NCD98.1.
4. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207-2212.
5. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538.
6. Bouchard C, Perusse L, Rice T, Rao DC. The genetics of human obesity. In: Bray GA, Bouchard C, James WP, eds. Handbook of Obesity. New York, NY: Marcel Dekker Inc; 1998:157-190.
7. Chagnon YC, Pérusse L, Weisnagel SJ, Rankinen T, Bouchard C. The human obesity gene map: the 1999 update. Obes Res. 2000;8:89-117.
8. Boozer CN, Schoenbach G, Atkinson RL. Dietary fat and adiposity: a dose-response relationship in adult rats fed isocalorically. Am J Physiol. 1995;268:E546-E550.
9. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr. 1998;68:1157-1173.
10. George V, Tremblay A, Després JP, Leblanc C, Bouchard C. Effect of dietary fat content on total and regional adiposity in men and women. Int J Obes. 1990; 14:1085-1094.
11. Ernst ND, Sempos CT, Briefel RR, Clark MB. Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Surveys. Am J Clin Nutr. 1997;66(suppl 4):965S-972S.
12. Flatt JP, Ravussin E, Acheson KJ, Jequier E. Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J Clin Invest. 1985; 76:1019-1024.
13. Rolls BJ, Miller DL. Is the low-fat message giving people a license to eat more? J Am Coll Nutr. 1997;16:535-543.
14. Zurlo F, Ferraro RT, Fontvieille AM, Rising R, Bogardus C, Ravussin E. Spontaneous physical activity and obesity: cross-sectional and longitudinal studies in Pima Indians. Am J Physiol 1992;263:E296-E300.
15. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science. 1999;283:212-214.
16. Pronk NP, Wing RR. Physical activity and long-term maintenance of weight loss. Obes Res. 1994;2:587-599.
17. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ. 1995;311: 437-439.
18. Gortmaker SL, Dietz WH Jr, Cheung LW. Inactivity, diet, and the fattening of America. J Am Diet Assoc. 1990;90:1247-1252, 1255.
19. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report. Obes Res. 1998;6(suppl 2): 51S-209S.
20. Bray GA, Bouchard C, James WP, ed. Handbook of Obesity. New York, NY: Marcel Dekker: 1997.
21. Magnusson A, Stefansson JG. Prevalence of seasonal affective disorder in Iceland. Arch Gen Psychiatry. 1993;50:941-946.
22. Bray GA. Syndromes of hypothalamic obesity in man. Pediatr Ann. 1984;13: 525-536.
23. Lang K, Sebok A, Katona G. The role of tonsillectomy in the development of childhood obesity. Orv Hetil. 1986;127:2303-2305.
24. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science. 1982;216:82-85.
25. Carter JK, Ow CL, Smith RE. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun. 1983;39: 410-422.
26. Gosztonyi G, Ludwig H, Borna disease: neuropathology and pathogenesis. Curr Top Microbiol Immunol. 1995;190:39-73.
27. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA. Effect of adenovirus infection on adiposity in chickens. Vet Microbiol. 1992;31:101-107.
28. Dhurandhar NV, Atkinson RL. Development of obesity in chickens after infection with a human adenovirus. Obes Res. 1996;4:24S.
29. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Adiposity in animals due to a human virus. Int J Obesity. In press.
30. Atkinson RL, Dhurandhar NV, Abbott DH, Darken N. Weight gain and reduced serum lipids in non-human primates due to a human virus [abstract]. Int J Obes. In press.
31. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BE. Evidence for an association of an obesity virus with human obesity at three sites in the United States [abstract]. Int J Obes. 1998;22(suppl 3):S57.
32. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Association of adenovirus infection with human obesity Obes Res. 1997;5:464-469.
33. Wigand R, Gelderblom H, Wadell G. New human adenovirus (candidate adnovirus 36), a novel member of subgroup D. Arch Virol. 1980;64:225-233.
34. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-660.
35. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
36. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes. 1992; 16:397-415.
37. Lamarche B, Tchernof A, Mauriege P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279:1955-1961.
38. Atkinson RL. Intravenous lidocaine for the treatment of intractable pain of adiposis dolorosa. Int J Obes. 1982;6:351-357.
39. Sugerman HJ, Felton WL III, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229:634-640.
40. Sugerman HJ, Felton WL III, Salvant JB Jr, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45:1655-1659.
41. Stunkard AJ. The Pain of Obesity. Palo Alto, Calif: Bull Publishing Co; 1976.
42. Rand CS, MacGregor AM. Successful weight loss following obesity surgery and the perceived liability of morbid obesity, Int J Obes. 1991;15:577-579.
43. Jakicic JM, Wing RR, Butler BA, Robertson RJ. Prescribing exercise in multiple short bouts versus one continuous bout: effects on adherence, cardiorespiratory fitness, and weight loss in overweight women. Int J Obes. 1995;19:893-901.
44. Munro JF, MacCuish AC, Wilson EM, Duncan LP. Comparison of continuous and intermittent anorectic therapy in obesity. BMJ. 1968;1:352-354.
45. Lean ME. Sibutramine - a review of clinical efficacy. Int J Obes 1997;21: S30-S36.
46. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281:235-242.
47. Bowen RL, Atkinson RL. Addition of orlistat to long term phentermine treatment for obesity [abstract]. Obes Res. 2000;8:118.
48. Weintraub M. Long term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther. 1992;51: 81-646.
49. Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997;65:79-85.
50. Martin LF, White S, Lindstrom W Jr. Cost benefit analysis for the treatment of severe obesity. World J Surg. 1998;22:1008-1017.
51. MacDonald KC, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213-220.
52. Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and roux-y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg. 1989;157:93-102.
53. Sugerman HJ, Baron PL, Fairman RP, Evans CR, Vetrovec GW. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg. 1988;207:604-613.
54. Kral JG. Surgical treatment of obesity. In: Bray GA, Bouchard C, James WP, eds. Handbook of Obesity. New York, NY: Marcel Dekker, 1997;977-993.
55. Sjostrom CD, Lissner L. Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res. 1999;7:477-484.